- Home
- ALHC vs APLS Comparison
ALHC vs APLS Comparison
Compare ALHC & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALHC
- APLS
- Stock Information
- Founded
- ALHC 2013
- APLS 2009
- Country
- ALHC United States
- APLS United States
- Employees
- ALHC N/A
- APLS N/A
- Industry
- ALHC Medical Specialities
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- ALHC Health Care
- APLS Health Care
- Exchange
- ALHC Nasdaq
- APLS Nasdaq
- Market Cap
- ALHC 2.7B
- APLS 3.5B
- IPO Year
- ALHC 2021
- APLS 2017
- Fundamental
- Price
- ALHC $16.36
- APLS $27.60
- Analyst Decision
- ALHC Buy
- APLS Buy
- Analyst Count
- ALHC 11
- APLS 20
- Target Price
- ALHC $18.14
- APLS $34.11
- AVG Volume (30 Days)
- ALHC 2.9M
- APLS 2.3M
- Earning Date
- ALHC 10-28-2025
- APLS 07-31-2025
- Dividend Yield
- ALHC N/A
- APLS N/A
- EPS Growth
- ALHC N/A
- APLS N/A
- EPS
- ALHC N/A
- APLS N/A
- Revenue
- ALHC $3,335,894,000.00
- APLS $754,649,000.00
- Revenue This Year
- ALHC $47.18
- APLS $20.59
- Revenue Next Year
- ALHC $28.45
- APLS N/A
- P/E Ratio
- ALHC N/A
- APLS N/A
- Revenue Growth
- ALHC 49.46
- APLS 20.02
- 52 Week Low
- ALHC $8.65
- APLS $16.10
- 52 Week High
- ALHC $21.06
- APLS $41.94
- Technical
- Relative Strength Index (RSI)
- ALHC 71.28
- APLS 71.41
- Support Level
- ALHC $15.38
- APLS $27.27
- Resistance Level
- ALHC $16.52
- APLS $28.70
- Average True Range (ATR)
- ALHC 0.54
- APLS 1.02
- MACD
- ALHC 0.13
- APLS -0.05
- Stochastic Oscillator
- ALHC 92.38
- APLS 83.89
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.